LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $73,000 | -39.7% | 13,117 | -27.9% | 0.04% | -35.9% |
| Q4 2018 | $121,000 | -55.0% | 18,200 | -27.8% | 0.06% | -45.3% |
| Q3 2018 | $269,000 | -41.4% | 25,209 | -34.1% | 0.12% | -19.9% |
| Q2 2018 | $459,000 | +18.3% | 38,275 | -15.5% | 0.15% | +55.3% |
| Q1 2018 | $388,000 | +3.2% | 45,273 | +48.0% | 0.09% | -11.3% |
| Q3 2017 | $376,000 | +154.1% | 30,600 | +197.1% | 0.11% | +76.7% |
| Q1 2017 | $148,000 | -51.8% | 10,300 | -53.6% | 0.06% | -62.7% |
| Q4 2016 | $307,000 | +12.0% | 22,200 | +16.2% | 0.16% | +21.1% |
| Q2 2016 | $274,000 | – | 19,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |